MDNAF Medicenna Therapeutics

Watchlist

0.705
0.0000.00%

15min DelayTrading Mar 21 15:20 ET

55.15MMarket Cap-2.73P/E (TTM)

Medicenna Therapeutics Key Stats

According to the latest financial report of Medicenna Therapeutics, the latest earnings per share (TTM) for the company is -0.07. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CAD

Quarterly

FCF

Interested in knowing about Medicenna Therapeutics's free cash flow? The latest report shows it as -3.56M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: CAD

Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Medicenna Therapeutics shows that the company's current ratio is 10.09, indicating healthy liquidity.

Currency: CAD

Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Medicenna Therapeutics, the quick ratio is 9.90, indicating that the company can meet its short-term debt obligations.

Currency: CAD

Quarterly

ROE

Want to learn more about the financial health of Medicenna Therapeutics? The latest ROE figure is -27.68%, indicating that the company has stable profitability.

Currency: CAD

Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Medicenna Therapeutics, the total asset return on investment (ROA) is -15.93%.

Currency: CAD

Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Medicenna Therapeutics's latest financial report to see how their gross margin is doing - currently at --.

Currency: CAD

Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Medicenna Therapeutics, the net profit margin is --, which is a good sign for its profitability.

Currency: CAD

Quarterly

MDNAF Medicenna Therapeutics

Medicenna Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Market Insights